| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 726028 | 84220 | VENLAFAXINA RETARD SANDOZ 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD SANDOZ 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 75 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84220/84220_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84220/84220_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-07-29 | 1 | 1 | 1 | 2019-07-29 | 2019-07-29 | 1 | 2021-07-14 | View Edit Delete | ||||||||||||
| 726096 | 84242 | EBASTINA AUROVITAS 20 MG COMPRIMIDOS BUCODISPERSABLES EFG | EBASTINA AUROVITAS 20 MG COMPRIMIDOS BUCODISPERSABLES EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84242/84242_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84242/84242_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-29 | 1 | 1 | 1 | 2019-07-29 | 2019-07-29 | 1 | 2020-08-31 | View Edit Delete | ||||||||||||
| 726101 | 84243 | EBASTINA AUROVITAS 10 MG COMPRIMIDOS BUCODISPERSABLES EFG | EBASTINA AUROVITAS 10 MG COMPRIMIDOS BUCODISPERSABLES EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84243/84243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84243/84243_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-29 | 1 | 1 | 1 | 2019-07-29 | 2019-07-29 | 1 | 2020-08-31 | View Edit Delete | ||||||||||||
| 726494 | 82878 | MONOPROST 50 MICROGRAMOS/ML COLIRIO EN SOLUCION | MONOPROST 50 MICROGRAMOS/ML COLIRIO EN SOLUCION , 1 frasco de 6 ml | 50 microgramos/ml | 6 | 6 | 26 | 1 frasco de 6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82878/82878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82878/82878_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2019-07-29 | 1 | 1 | 1 | 2019-07-29 | 2019-07-29 | 1 | 2026-02-16 | View Edit Delete | ||||||||||||
| 726444 | 84378 | SILODOSINA KRKA 4 MG CAPSULAS DURAS EFG | SILODOSINA KRKA 4 MG CAPSULAS DURAS EFG, 30 cápsulas | 4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84378/84378_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84378/84378_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2019-07-24 | 1 | 1 | 1 | 2019-07-25 | 2019-07-24 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 726445 | 84379 | SILODOSINA KRKA 8 MG CAPSULAS DURAS EFG | SILODOSINA KRKA 8 MG CAPSULAS DURAS EFG, 30 cápsulas | 8 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84379/84379_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84379/84379_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2019-07-24 | 1 | 1 | 1 | 2019-07-25 | 2019-07-24 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 726297 | 1191377001 | TALZENNA 0,25 MG CAPSULAS DURAS | TALZENNA 0,25 MG CAPSULAS DURAS, 30 cápsulas | 0,25 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191377001/1191377001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191377001/1191377001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2019-07-24 | 1 | 1 | 1 | 2019-07-25 | 2019-07-24 | 1 | 2024-12-13 | View Edit Delete | ||||||||||||
| 726403 | 84368 | GANCICLOVIR ACCORD 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | GANCICLOVIR ACCORD 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales | 500 mg | 45 | 5 | 34 | 5 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84368/84368_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84368/84368_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2019-07-23 | 1 | 1 | 1 | 2019-07-24 | 2019-07-23 | 0 | 2019-12-12 | View Edit Delete | ||||||||||||
| 764355 | 84207 | RIVASTIGMINA AUROVITAS SPAIN 9,5 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 9,5 MG/24 H PARCHES TRANSDERMICOS EFG, 60 sobres (2 X 30) parches transdérmicos, (Papel/PET/PE/Al/LasPolD) | 9,5 mg/24 h | 35 | 60 | 28 | 60 sobres (2 X 30) parches transdérmicos, (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84207/84207_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84207/84207_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-02-16 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 764408 | 84206 | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 30 parches transdérmicos (Papel/PET/PE/Al/LasPolD) | 4,6 mg/24 h | 35 | 30 | 28 | 30 parches transdérmicos (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84206/84206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84206/84206_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-02-22 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 764518 | 84206 | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 60 parches transdérmicos ( 2 x 30) (Papel/PET/PE/Al/LasPolD) | 4,6 mg/24 h | 35 | 60 | 28 | 60 parches transdérmicos ( 2 x 30) (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84206/84206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84206/84206_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-03-11 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 711262 | 1161092032 | AMLODIPINO/VALSARTAN MYLAN 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN MYLAN 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (unidosis) | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos (unidosis) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161092032/1161092032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161092032/1161092032_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38088 | VIATRIS PHARMACEUTICALS S.L.U. | 2016-06-23 | 1 | 1 | 1 | 2019-07-23 | 2019-07-23 | 0 | 2019-10-11 | View Edit Delete | ||||||||||||
| 711263 | 1161092019 | AMLODIPINO/VALSARTAN MYLAN 5 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN MYLAN 5 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (unidosis) | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos (unidosis) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161092019/1161092019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161092019/1161092019_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38088 | VIATRIS PHARMACEUTICALS S.L.U. | 2016-06-23 | 1 | 1 | 1 | 2019-07-23 | 2019-07-23 | 0 | 2019-10-11 | View Edit Delete | ||||||||||||
| 726425 | 84372 | DEXMEDETOMIDINA ALTAN 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | DEXMEDETOMIDINA ALTAN 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 25 ampollas de 2 ml | 100 microgramos/ml inyectable 2 ml | 1 | 25 | 1 | 25 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84372/84372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84372/84372_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | ALTAN PHARMACEUTICALS SA | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2020-03-06 | View Edit Delete | ||||||||||||
| 726404 | 04307004IP1 | ZONEGRAN 100 MG CAPSULAS DURAS | ZONEGRAN 100 mg CAPSULAS DURAS, 56 cápsulas | 100 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04307004IP1%20%20/04307004IP1___ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04307004IP1%20%20/04307004IP1___p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8130 | ELAM PHARMA LABS S.L. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2020-01-14 | View Edit Delete | ||||||||||||
| 726426 | 84373 | FINASTERIDA MABO 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FINASTERIDA MABO 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84373/84373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84373/84373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2020-02-11 | View Edit Delete | ||||||||||||
| 726427 | 84373 | FINASTERIDA MABO 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FINASTERIDA MABO 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 98 comprimidos | 1 mg | 5 | 98 | 10 | 98 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84373/84373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84373/84373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2020-02-11 | View Edit Delete | ||||||||||||
| 726132 | 1181318005 | SLENYTO 1 MG COMPRIMIDOS DE LIBERACION PROLONGADA | SLENYTO 1 MG COMPRIMIDOS DE LIBERACION PROLONGADA 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181318005/1181318005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181318005/1181318005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31764 | EXELTIS HEALTHCARE S.L. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2022-01-04 | View Edit Delete | ||||||||||||
| 726336 | 1191370001 | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, Frasco de 30 comprimidos | 50 mg/300 mg | 6 | 30 | 10 | Frasco de 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191370001/1191370001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191370001/1191370001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | LABORATORIOS VIIV HEALTHCARE S.L. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 729747 | 84372 | DEXMEDETOMIDINA ALTAN 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | DEXMEDETOMIDINA ALTAN 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 4 viales de 10 ml | 100 microgramos/ml inyectable 10 ml | 45 | 4 | 34 | 4 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84372/84372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84372/84372_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | ALTAN PHARMACEUTICALS SA | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2020-11-11 | 1 | 2025-11-14 | View Edit Delete |
Page 264 of 1036, showing 20 records out of 20703 total, starting on record 5261, ending on 5280